Old Web
English
Sign In
Acemap
>
authorDetail
>
Yejun Si
Yejun Si
Medicine
Internal medicine
Immunology
Myeloid leukemia
Cytarabine
4
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comparison of the efficacy and impact of GEMOX and GDP in the treatment of patients with non-Hodgkin's lymphoma.
2020
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Xingxia Zhang
Baoran Wang
Weiguo Tao
Yejun Si
Guoqiang Lin
Yanming Zhang
Ran Liu
Wenzhi Yuan
Show All
Source
Cite
Save
Citations (1)
Decitabine compared with conventional regimens in older patients with acute myeloid leukemia: A meta-analysis
2019
Clinical Lymphoma, Myeloma & Leukemia
Mei-Ru Bian
Han Shi-yang
Guo-Qiang Lin
Yan Wan
Li Wang
Yejun Si
Xin-Xia Zhang
Mao Wang
Hua Zhou
Guang Sheng Zhao
Yanming Zhang
Show All
Source
Cite
Save
Citations (2)
Myeloid Antigen-positive T Cell Acute Lymphocytic Leukemia with t(14;18) and Trisomy 10: Report of a Case and Literature Review
2015
Archives of Iranian Medicine
Guoqiang Lin
Limin Liu
Guangsheng Zhao
Yejun Si
Xingxia Zhang
Yumei Sun
Shuhua Lu
Yanming Zhang
Show All
Source
Cite
Save
Citations (1)
Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia
2014
International Journal of Hematology
Limin Liu
Yanming Zhang
Zhengming Jin
Xingxia Zhang
Guangsheng Zhao
Yejun Si
Guoqiang Lin
Aidi Ma
Yingxin Sun
Li Wang
Depei Wu
Show All
Source
Cite
Save
Citations (12)
1